Given the immediate growth and ever-changing nature of cold-chain logistics, ensuring pharma companies have the flexibility to handle temperature-controlled products safely and securely in the supply chain is critical.
In this report, Pharma Logistics IQ explores the benefits of using a hybrid container solution in cold-chain handling to maximize process efficiencies, fulfill a sudden rise in on demand deliveries and enhance pharma’s sustainable initiatives.
The report also dives into insights and real-life case studies from Merck, Agilent Technologies and SkyCell to help pharma companies improve their implementation strategies for hybrid containers.
Download the report to discover:
- Where to find shipping containers designed for cold-chain handling and advanced end-to-end supply chain visibility.
- How to protect pharmaceutical shipments from temperature excursions, shock and vibrations.
- Why the future of supply chain logistics lies with hybrid systems.